Navigation Links
Cephalon Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ
Date:7/21/2011

ng to patients appropriate for the medications.  All stakeholders can enroll in the system any time beginning in September 2011.  There will be a transition period of about six months following launch of the REMS after which no prescription may be dispensed unless the prescriber and pharmacy are enrolled.    

Cephalon will provide regular updates to FDA regarding the effectiveness of the REMS.  Based on these evaluations, Cephalon plans to open discussions with FDA regarding the Company's pending supplemental New Drug Application for FENTORA as a treatment for opioid-tolerant patients with non-cancer breakthrough pain.

Important Safety Information

WARNING: IMPORTANCE OF PROPER PATIENT SELECTION, DOSING, and POTENTIAL FOR ABUSE

Reports of serious adverse events, including deaths in patients treated with ACTIQ® have been reported.  Deaths occurred as a result of improper patient selection (e.g., use in opioid non-tolerant patients) and/or improper dosing. The substitution of ACTIQ for any other fentanyl product may result in fatal overdose.

ACTIQ is indicated only for the management of breakthrough cancer pain in patients with malignancies who are already receiving and who are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain. Patients considered opioid tolerant are those who are taking around-the-clock medicine consisting of at least 60 mg of oral morphine daily, at least 25 mcg of transdermal fentanyl/hour, at least 30 mg of oral oxycodone daily, at least 8 mg oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer.

ACTIQ is not indicated for use in opioid non-tolerant patients including those with only as needed (PRN) prior exposure.

Life-threatening respiratory depression could occur at any dose in opioid non-tolerant pa
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cephalon Shareholders Approve Acquisition by Teva
2. Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction
3. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
4. Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
5. Cephalon Lodges Bidders Statement for A$167 Million Offer for ChemGenex Pharmaceuticals
6. Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
7. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
8. Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited
9. Cephalon Wins FENTORA Patent Suit Against Watson
10. Cephalon Announces Definitive Agreement to Acquire Gemin X
11. Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
(Date:12/17/2014)... Ga. and RALEIGH, N.C. ... Trial Marketing Communications, LLC (CTMC), and Integrated Clinical ... patient recruitment and retention for clinical trials announce ... Integrated Clinical Trial Marketing Services (i-CTMS). i-CTMS will ... retention services to pharmaceutical, biotechnology and medical device ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "MEMS Gyroscopes Analog ... Analysis" report to their offering. ... gyroscopes for tactical grade applications made a lot ... term of reliability. They are now accepted in ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2
... and economic advantages of nifedipine,GITS therapy , ... 2007 – Two recently,published articles in the ... the use of the long-acting calcium channel,blocker ... beyond its blood pressure lowing effect. A ...
... Interleukin,Genetics, Inc. (AMEX:ILI) and collaborators at the ... the American College of,Cardiology annual meeting that ... oxidized phospholipids (OxPL) and Lp(a),levels appear to ... (IL-1) genes., In a presentation titled "The ...
Cached Medicine Technology:Calcium Channel Blocker Adalat GITS Offer Additional Benefits 2Calcium Channel Blocker Adalat GITS Offer Additional Benefits 3ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 2ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 3
(Date:12/19/2014)... THURSDAY, Dec. 18, 2014 (HealthDay News) -- A new ... -- moderate to severe hot flashes and night sweats ... bones. Hot flashes are common during menopause, affecting ... menopause also affect women after menopause, since they then ... "Our findings suggest women who exhibit moderate or ...
(Date:12/19/2014)... Norton HealthDay Reporter THURSDAY, ... who were exposed to high levels of air pollution late ... a U.S. study suggests. Researchers found that of nearly ... those exposed to the most air pollution during pregnancy were ... autism. And exposure during the third trimester, specifically, showed the ...
(Date:12/19/2014)... (HealthDay News) -- Traveling through the same U.S. airport ... three others within a four-hour time span, illustrating just ... shows. "The exposures in this report were not ... international terminal, highlighting the fact that measles is highly ... infectious disease specialist at the U.S. Centers for Disease ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, Dec. 18, ... leg for at least 20 seconds you may be at ... on one leg may indicate that small strokes or tiny ... serious strokes is high, the investigators reported online Dec. 18 ... while standing on one leg, as well as problems walking, ...
(Date:12/17/2014)... Myo Nwe is the co-author of a new weight loss ... of the Ace Medical Weight Loss Center in Rock Hill, ... at the industry of weight loss, and how several fad ... in television shows, however, she says the topic of obesity ... for basic laughs, which she believes impacts whether Americans view ...
Breaking Medicine News(10 mins):Health News:Severe Hot Flashes During Menopause May Raise Hip Fracture Risk Later: Study 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3Health News:Arriving Now at Gate 42: Measles 2Health News:Arriving Now at Gate 42: Measles 3Health News:Can You Balance on One Leg? You May Have Lower Stroke Risk 2Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2
... about his health care plan to SpineUniverse.com, whose recent survey results ... ... Montclair, NJ (PRWEB) October 31, 2008 -- Senator Barack ... care plan to SpineUniverse.com. Now every visitor to SpineUniverse.com -- ...
... The art and science of hormone,balancing vs. hormone replacement ... believe that breast cancer and its risks can be ... the landmark book, "What Your Doctor May Not Tell ... Your Life", nearly all risk,factors associated with breast cancer ...
... cancer related to HBV viral infection in Asian countries, ... treated by surgical resection including liver transplantation and non-surgical ... lung, so called lung metastasis from liver cancer is ... are very advanced and too late in being adequately ...
... for a Healthy Pet(R), contest sponsored by Morris,Animal ... DENVER, Oct. 31 Veterinarians provide our pets ... healthy and happy lives. To,recognize their efforts, hundreds ... "Thank Your Vet for a Healthy Pet(R)" contest, ...
... 31 A new report shows many are ... Here,s more on ways to get the,most out ... staying healthy., Listen to this report ... can access video, audio, text, graphics and,photos for ...
... WASHINGTON, Oct. 31 In the final 72-hours ... other volunteers,across the country are joining 4,000 SEIU ... off the job to bring home victory for,Barack ... change working,families need., SEIU,s major GOTV operations ...
Cached Medicine News:Health News:Senator Obama Explains His Health Care Plan to SpineUniverse.com 2Health News:Senator Obama Explains His Health Care Plan to SpineUniverse.com 3Health News:Natural Hormone Balance: Gaining Ground in the Fight Against Breast Cancer 2Health News:If metastasectomy should be performed before other treatments 2Health News:Hundreds of Pet Owners Nominate Veterinarians in Nationwide Contest to Find America's Best Vet 2Health News:Hundreds of Pet Owners Nominate Veterinarians in Nationwide Contest to Find America's Best Vet 3Health News:In Final 72-Hour Push, SEIU Members Get Out The Vote for Barack Obama and Other Working Family Candidates Across the Country 2
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries....
Medicine Products: